Placental growth factor-2 gene transfer by electroporation restores diabetic sensory neuropathy in mice

Experimental Neurology

Volumn 227, Issue 1, 2011, Pages 195-202

  Murakami, Tatsufumi ^a   Imada, Yoshimi ^b   Kawamura, Mai ^b   Takahashi, Tomoko ^c   Fujita, Yoshiaki ^c   Sato, Eiji ^b   Yoshitomi, Hironori ^b   Sunada, Yoshihide ^a   Nakamura, Akihiro ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b FUKUYAMA UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Diabetic neuropathy; Electroporation; Gene therapy; Hypoalgesia; Neuropilin 1; Placental growth factor 2

Indexed keywords

NEUROPILIN 1; PLACENTAL GROWTH FACTOR; PLACENTAL GROWTH FACTOR 2; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ELECTROPORATION; ENDONEURIUM; GENE OVEREXPRESSION; HYPOALGESIA; MOUSE; NERVE CONDUCTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PAIN THRESHOLD; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SCIATIC NERVE; SENSORY NEUROPATHY; SPINAL GANGLION; STREPTOZOCIN DIABETES; TIBIALIS ANTERIOR MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD3; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL LATERALITY; GENE THERAPY; HUMANS; HYPERALGESIA; MALE; MICE; MUSCLE, SKELETAL; NEURAL CONDUCTION; PAIN THRESHOLD; PREGNANCY PROTEINS; REACTION TIME; SCIATIC NERVE; STATISTICS, NONPARAMETRIC; UBIQUITIN THIOLESTERASE;

EID: 78650934978     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.10.015     Document Type: Article

References (36)

1. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.-M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.-M., Collen D., Persico M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 2001, 7:575-583.
2. Chattopadhyay M., Krisky D., Wolfe D., Glorioso J.C., Mata M., Fink D.J. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther. 2005, 12:1377-1384.
3. Cheng L., Jia H., Löhr M., Bagherzadeh A., Holmes D.I.R., Selwood D., Zachary I. Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production. J. Biol. Chem. 2004, 279:30654-30661.
4. Christianson J.A., Ryals J.M., McCarson K.E., Wright D.E. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice. J. Pain 2003, 4:493-504.
5. Christianson J.A., Riekhof J.T., Wright D.E. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 2003, 179:188-199.
6. Clauss M., Weich H., Breier G., Knies U., Röckl W., Waltenberger J., Risau W. The vascular endothelial growth factor receptor flt-1 mediates biological activities. J. Biol. Chem. 1996, 271:17629-17634.
7. Gavazzi I., Stonehouse J., Sandvig A., Reza J.N., Appiah-Kubi L.S., Keynes R., Cohen J. Peripheral, but not central, axotomy induces neuropilin-1 mRNA expression in adult large diameter primary sensory neurons. J. Comp. Neurol. 2000, 423:492-499.
8. Hartikka J., Sukhu L., Buchner C., Hazard D., Bozoukova V., Margalith M., Nishioka W.K., Wheeler C.J., Manthorpe M., Sawdey M. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol. Ther. 2001, 4:407-415.
9. Hauser S., Weich H.A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and placenta. Growth Factors 1993, 9:259-268.
10. Khurana R., Moons L., Shafi S., Luttun A., Collen D., Martin J.F., Carmeliet P., Zachary I.C. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 2005, 111:2828-2836.
11. Kurokawa K., de Almeida D.F., Zhang Y., Hébert C.D., Page J.G., Schweikart K.M., Oh S.J. Sensory nerve conduction of the plantar nerve compared with other nerve conduction tests in rats. Clin. Neurophysiol. 2004, 115:1677-1682.
12. Kutcher M.E., Klagsbrun M., Mamluk R. VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development. FASEB J. 2004, 18:1952-1954.
13. Livingston J.C., Chin R., Haddad B., McKinney E.T., Ahokas R., Sibai B.M. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am. J. Obstet. Gynecol. 2000, 183:1554-1557.
14. Llewelyn J.G., Tomlinson D.R., Thomas P.K. Diabetic neuropathies. Peripheral Neuropathy 2005, 1951-1991. Elsevier, Philadelphia. 4th ed. P.J. Dyck, P.K. Thomas (Eds.).
15. Maglione D., Guerriero V., Viglietto G., Ferraro M.G., Aprelikova O., Alitalo K., Del Vecchio S., Lei K.-J., Chou J.Y., Persico M.G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993, 8:925-931.
16. Mamluk R., Gechtman Z., Kutcher M.E., Gasiunas N., Gallagher J., Klagsbrun M. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J. Biol. Chem. 2002, 277:24818-24825.
17. Miao H.-Q., Soker S., Feiner L., Alonson J.L., Raper J.A., Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 1999, 146:233-241.
18. Migdal M., Huppertz B., Tessler S., Comfort A., Shibuya M., Reich R., Baumann H., Neufeld G. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 1998, 273:22272-22278.
19. Murakami T., Nishi T., Kimura E., Goto T., Maeda Y., Ushio Y., Uchino M., Sunada Y. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation. Muscle Nerve 2003, 27:237-241.
20. Murakami T., Arai M., Sunada Y., Nakamura A. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J. Gene Med. 2006, 8:773-781.
21. Obrosova I.G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009, 6:638-647.
22. Olsson A.-K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7:359-371.
23. Pasterkamp R.J., Giger R.J., Verhaagen J. Regulation of semaphorin III/Collapsin-1 gene expression during peripheral nerve regeneration. Exp. Neurol. 1998, 153:313-327.
24. Pradat P.-F., Finiels F., Kennel P., Naimi S., Orsini C., Delaere P., Revah F., Mallet J. Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Hum. Gene Ther. 2001, 12:367-375.
25. Pradat P.-F., Kennel P., Naimi-Sadaoui S., Finiels F., Scherman D., Orsini C., Delaere P., Mallet J., Revah F. Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Ther. 2002, 9:1333-1337.
26. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 1957, 4:409-419.
27. Reza J.N., Gavazzi I., Cohen J. Neuropilin-1 is expressed on adult mammalian dorsal root ganglion neurons and mediates semaphorin3a/collapsin-1-induced growth cone collapse by small diameter sensory afferents. Mol. Cell. Neurosci. 1999, 14:317-326.
28. Robertson D.M., Sima A.A.F. Diabetic neuropathy in the mutant mouse [C57BL/ks(db/db)]. Diabetes 1980, 29:60-67.
29. Ropper A.H., Gorson K.C., Gooch C.L., Weinberg D.H., Pieczek A., Ware J.H., Kershen J., Rogers A., Simovic D., Schratzberger P., Kirchmair R., Losordo D. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann. Neurol. 2009, 65:386-393.
30. Sawano A., Takahashi T., Yamaguchi S., Aonuma M., Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 1996, 7:213-221.
31. Schratzberger P., Walter D.H., Rittig K., Bahlmann F.H., Pola R., Curry C., Silver M., Krainin J.G., Weinberg D.H., Ropper A.H., Isner J.M. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 2001, 107:1083-1092.
32. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 1999, 19:5731-5740.
33. Tokui M., Takei I., Tashiro F., Shimada A., Kasuga A., Ishii M., Ishii T., Takatsu K., Saruta T., Miyazaki J. Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. Biochem. Biophys. Res. Commun. 1997, 233:527-531.
34. Whiteley S.J., Tomlinson D.R. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Exp. Neurol. 1985, 89:314-321.
35. Yagihashi S., Yamagishi S.-I., Wada R., Baba M., Hohman T.C., Yabe-Nishimura C., Kokai Y. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 2001, 124:2448-2458.
36. Yang W., Ahn H., Hinrichs M., Torry R.J., Torry D.S. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J. Reprod. Immunol. 2003, 60:53-60.